KEYNOTE SPEAKER INFORMATION
Matthew Tredwell performed undergraduate and postgraduate studies at the University of Oxford, followed by postdoctoral research stays at the University of Cambridge, and subsequently the University of Oxford. Matthew started his independent career in 2015 at the Max-Planck-Institut für Kohlenforschung, before moving his research group to Cardiff University in 2019. His research interests are broadly centered around organofluorine chemistry, radiochemistry and molecular imaging.
Peter Scott is an Associate Professor of Radiology at the University of Michigan, as well as Director of the PET Center. Scott's group is involved in all aspects of Radiopharmaceutical Sciences including i) developing new methods for radiolabeling bioactive molecules, ii) design and synthesis of new radiotracers for PET imaging, and iii) cGMP radiopharmaceutical manufacture. His laboratory is funded by the U.S. DOE and NIH and collaborates with academic institutions, biotech and pharma companies all over the world.
François Guérard completed his PhD in organic chemistry and radiochemistry in 2010 at the University of Nantes (France) where he studied astatine labeling chemistry. He then joined Dr. Brechbiel’s Radioimmune & Inorganic Chemistry group at the National Cancer Institute (USA) as a post-doctoral fellow where he worked on Zr-89 complexation chemistry. He was appointed CNRS researcher in 2017 in the Centre for Research in Cancerology and Immunology, Nuclear Oncology Group (Nantes, France) where he is in charge of the Astatine-211 radiolabeling chemistry program.
John Clark is a Professor Emeritus of the University of Edinburgh. He was a founding member of The International Workshop on Targetry and Target Chemistry (WTTC) and The European Molecular Imaging Society (ESMI). As a member of the VU Medical Center advisory board and Chair of the GE Medical Systems Radiopharmacy User Forum and fulfilling other roles, John has—among other accomplishments—advanced automation of radiopharmacy chemistry and the development of targetry interfaces between engineering physics and chemistry.
Tony Gee is Professor of PET and Radiochemistry in the Division of Imaging Sciences at King's College London and a visiting Professor at the Department of Chemistry, Imperial College London. He is a member the scientific boards of the Society of Radiopharmaceutical Sciences, the EANM Drug Development Group, RSC Radiopharmacy Group, Medical Imaging Probes & Biosensors for BioimagingUK. His research is on rapid labeling, synthetic techniques with short-lived positron-emitting radionuclides, small molecule-protein / small molecule-membrane interactions, the design of PET probes, and the understanding of in vivo pharmacology.